Wiley Periodical, Inc.
ANZET16 – Adelaide, 2-4 August 2016
10th Annual Australian & New Zealand Endovascular Therapies Meeting
Speaker: Keith Oldroyd, Scotland
Duration: 25 min
Today’s most in-depth single source on vascular diseases. It integrates the very latest understanding of vascular biology with detailed, state-of-the-art reviews of pathophysiology, diagnosis, and management. The comprehensive and clinically oriented coverage equips you to effectively evaluate patients with a broad range of vascular diseases, and to implement the most appropriate diagnostic and therapeutic strategies available today.
This volume enables practitioners to assess the adverse effects of the complete range of drugs used in cardiovascular medicine, including antihypertensive drugs, and drugs used in the treatment of heart failure, angina, angina pectoris, and cardiac arrhythmia and enable practitioners to prescribe preventative treatments with medications such as blood pressure reducers, aspirin, and cholesterol-lowering drugs, as well as drugs used for more aggressive therapy.
Journal of Cardiac Failure publishes original, peer-reviewed communications of scientific excellence and review articles on clinical research, basic human studies, animal studies, and bench research with potential clinical applications to heart failure – pathogenesis, etiology, epidemiology, pathophysiological mechanisms, assessment, prevention, and treatment.
Official Journal of the Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis and the Italian Society of Human Nutrition
Nutrition, Metabolism & Cardiovascular Diseases is a forum designed to focus on the powerful interplay between nutritional and metabolic alterations, and cardiovascular disorders.
Vascular Pharmacology publishes papers, which contains results of all aspects of biology and pharmacology of the vascular system.
The Canadian Journal of Cardiology (CJC) is the official journal of the Canadian Cardiovascular Society (CCS). The CJC is a vehicle for the international dissemination of new knowledge in cardiology and cardiovascular science, particularly serving as the major venue for Canadian cardiovascular medicine.
Atherosclerosis brings together from all sources papers concerned with research and investigation on atherosclerosis, its complications, and related diseases, including: lipoprotein metabolism, arterial and vascular biology and disease, thrombosis, inflammation, disorders of lipid transport, diabetes and hypertension as related to atherosclerosis, and cardiovascular risk factors.
The Journal of Molecular and Cellular Cardiology publishes work advancing knowledge of the mechanisms responsible for both normal and diseased cardiovascular function. To this end papers are published in all relevant areas. These include (but are not limited to): structural biology; genetics; proteomics; morphology; stem cells; molecular biology; metabolism; biophysics; electrophysiology; pharmacology and physiology. Papers are encouraged with both basic and translational approaches. The journal is directed not only to basic scientists but also to clinical cardiologists who wish to follow the rapidly advancing frontiers of basic knowledge of the heart and circulation.